Interview with Zheng-Rong Lu, PhD
I was attracted to the field of nucleic acid therapeutics by the news of 2006 Nobel Prize in Medicine to Andrew Fire and Craig Mello when I was a junior
Interview with Jeroen Bremer, PhD
I became interested into the field of RNA-therapeutics during an internship at the department of Dermatology at the UMCG. Together with Peter van den
Interview with Annika de Jong, MSc, PhD Candidate
The first internship of my master was performed at the department of Human Genetics at the Leiden University Medical Centre where Prof. AnnemiekeAartsma-Rus
Interview with Robert Habib, MBA
In 2013 I was seeking to run a business that could have an impact in healthcare. John Rossi, PĂ¥l Sætrom and Nagy Habib had put together the initial features
Interview with Vadim Y Dudkin, PhD
I first became exposed to oligonucleotide delivery while at Merck upon the acquisition of Sirna in 2006. Part of my work at the time involved glyco
Interview with Hannah Pendergraff, PhD
I became interested in oligo therapeutics when I started working in David Corey’s lab. I joined his group in 2009...
Interview with Keith T. Gagnon, PhD
I was thrown into the world of nucleic acid therapeutics during my postdoc with David Corey. Â My Ph.D. training focused on the...
Interview with Paul Burke, PhD
Paul Burke, PhD Principal, Burke Bioventures LLC How did you become interested in the field of oligonucleotides? I first became interested in
Interview with Kotaro Yoshioka, MD, PhD
Kotaro Yoshioka, MD, PhD Department of Neurology and Neurological Science, Tokyo Medical and Dental University How did you become interested in the field of
Interview with Thorleif Møller, PhD
ThorleifMøller, PhD Mirrx Therapeutics A/S CEO & Founder How did you become interested in the field of oligonucleotides? During my PhD studies at the